@inproceedings{inproceedings, title = {{Preclinical Investigation of Inhibition of the DNA Damage Response as a Targetted Therapy in Myeloproliferative Neoplasms Shows Synergism of ATR Inhibitors with Standard-of-Care Treatment}}, publisher = {{MDPI}}, url = {{http://dx.doi.org/10.3390/iecc2021-09209 }}, year = {{2021}}, month = {{1}}, author = {{艢lusarczyk A and Bryant HE and Chen E and Hitchcock I and Zeidler M and Chantry A and Thomas S}}, doi = {{10.3390/iecc2021-09209}}, volume = {{129}}, journal = {{The 1st International Electronic Conference on Cancers: Exploiting Cancer Vulnerability by Targeting the DNA Damage Response}}, pages = {{17-17}}, note = {{Accessed on 2025/06/18}}}